Official Statistics

Mefloquine (Lariam) prescribing in the UK armed forces: 12 September 2016 to 31 March 2021

This statistical bulletin presents a summary of mefloquine prescribing following the introduction of a new policy in September 2016.

• From: Ministry of Defence
• Published: 13 May 2021

Documents

Mefloquine Prescribing in UK Armed Forces 12 September 2016 to 31 March 2021

HTML

Background Quality Report Mefloquine Prescribing in the UK Armed Forces

HTML

Mefloquine Prescribing in the UK Armed Forces Supplementary tables - O

ODS, 78.9 KB

This file is in an OpenDocument format

Mefloquine Prescribing in the UK Armed Forces Supplementary tables - O

MS Excel Spreadsheet, 2 MB

Details

Mefloquine (also known as Lariam) is used to prevent or treat malaria. It may be prescribed as one of a number of alternative chemoprophylactic drugs for military personnel deployed to areas where there is a high risk of chloroquine resistant malaria. This biannual official statistic provides information on the number of mefloquine prescriptions given to UK armed forces personnel at MOD medical facilities covering the period 12 September 2016 to 31 March 2021 with the focus on the latest six-month period (1 October 2020 to 31 March 2021).

Published 13 May 2021